HACQU Files S-1/A for $250M IPO, Cites Significant Dilution Risks

TL;DR

**Avoid HACQU; the significant dilution and inherent conflicts of interest heavily favor the sponsor, making it a high-risk bet for public shareholders.**

AI Summary

HCM IV Acquisition Corp. (HACQU) filed an S-1/A on November 24, 2025, for an initial public offering of 25,000,000 units at $10.00 per unit, aiming to raise $250,000,000. Each unit comprises one Class A ordinary share and one-fourth of one redeemable warrant, with each whole warrant exercisable at $11.50 per share. The SPAC is a blank check company seeking a business combination within 24 months of the offering's closing. The sponsor, HCM Investor Holdings IV, LLC, and Cantor Fitzgerald & Co. will purchase 4,666,667 private placement warrants for $7,000,000, exercisable at $11.50 per share. Public shareholders face significant dilution risks from the sponsor's nominal purchase price for 8,625,000 Class B ordinary shares and potential anti-dilution adjustments, which could result in Class A shares being issued on a greater than one-to-one basis upon conversion. Additionally, up to $1,500,000 in working capital loans from the sponsor may convert into 1,000,000 private placement warrants at $1.50 each, further diluting public shareholders. The company will also repay up to $300,000 in sponsor loans and pay an affiliate $35,000 monthly for administrative services, highlighting potential conflicts of interest.

Why It Matters

This S-1/A filing reveals a SPAC structure with substantial potential for dilution, which is critical for investors to understand. The nominal price paid by the sponsor for founder shares and the anti-dilution provisions mean public shareholders could see their equity significantly devalued post-business combination. For employees of a potential target, the SPAC's structure and management incentives could influence the long-term stability and value of their company. Customers might see impacts on product development or service quality if the combined entity struggles with capital or strategic direction due to these financial structures. In the competitive SPAC market, HACQU's terms, particularly the dilution and conflict of interest disclosures, could make it less attractive compared to SPACs with more shareholder-friendly structures.

Risk Assessment

Risk Level: high — The risk level is high due to multiple factors detailed in the filing. Public shareholders will incur 'immediate and substantial dilution' from the sponsor's purchase of 8,625,000 Class B ordinary shares for a 'nominal price' of $25,000. Furthermore, the anti-dilution rights of Class B ordinary shares could result in Class A ordinary shares being issued on a 'greater than one-to-one basis' upon conversion, potentially maintaining the sponsor's ownership at approximately 30% post-business combination, even with additional issuances. The potential conversion of up to $1,500,000 in working capital loans into 1,000,000 private placement warrants at $1.50 each also presents a material dilution risk.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the significant dilution risks and potential conflicts of interest before considering an investment in HACQU. Given the sponsor's substantial profit potential even if the business combination underperforms, it would be prudent to wait for a definitive business combination target and assess its terms carefully, or consider other SPACs with more favorable shareholder structures.

Financial Highlights

debt To Equity

0.0

revenue

$0

operating Margin

N/A

total Assets

$250,000,000

total Debt

$0

net Income

$0

eps

$0.00

gross Margin

N/A

cash Position

$243,000,000

revenue Growth

N/A

Key Numbers

• $250,000,000 — Total offering size (Targeted capital raise from the IPO of 25,000,000 units at $10.00 each)
• 25,000,000 — Units offered (Number of units being sold in the initial public offering)
• $10.00 — Offering price per unit (Price at which each unit is sold to the public)
• 4,666,667 — Private placement warrants (Number of warrants to be purchased by the sponsor and Cantor Fitzgerald & Co.)
• $7,000,000 — Aggregate private placement warrant purchase price (Total amount paid by the sponsor and Cantor Fitzgerald & Co. for private placement warrants)
• $11.50 — Warrant exercise price (Price at which each whole warrant can be exercised to purchase one Class A ordinary share)
• 8,625,000 — Class B ordinary shares (Number of founder shares purchased by the sponsor for a nominal price)
• $25,000 — Sponsor's purchase price for founder shares (Nominal aggregate price paid by the sponsor for 8,625,000 Class B ordinary shares)
• $1,500,000 — Maximum convertible working capital loans (Amount of sponsor loans convertible into private placement warrants at $1.50 per warrant)
• $35,000 — Monthly administrative fee (Amount paid monthly to an affiliate of the sponsor for office space and services)

Key Players & Entities

• HCM IV Acquisition Corp. (company) — Registrant and blank check company
• Shawn Matthews (person) — Chairman and Chief Executive Officer of HCM IV Acquisition Corp.
• HCM Investor Holdings IV, LLC (company) — Sponsor of HCM IV Acquisition Corp.
• Cantor Fitzgerald & Co. (company) — Representative of the underwriters
• King & Spalding LLP (company) — Legal counsel for the registrant
• Ellenoff Grossman & Schole LLP (company) — Legal counsel for the registrant
• Securities and Exchange Commission (regulator) — Regulatory body overseeing the filing
• Nasdaq (company) — Intended listing exchange for securities
• Inflation Reduction Act of 2022 (regulator) — Legislation impacting potential excise tax on redemptions
• Cayman Islands (regulator) — Jurisdiction of incorporation for HCM IV Acquisition Corp.

FAQ

Risk Factors

• Dilution from Sponsor Shares and Warrants [high — financial]: Public shareholders face significant dilution from the sponsor's purchase of 8,625,000 Class B ordinary shares for a nominal price of $25,000. Further dilution can occur through anti-dilution adjustments on these shares and the potential conversion of up to $1,500,000 in sponsor working capital loans into 1,000,000 private placement warrants at $1.50 each.
• Private Placement Warrant Dilution [medium — financial]: The sponsor and Cantor Fitzgerald & Co. are purchasing 4,666,667 private placement warrants for $7,000,000, or $1.50 per warrant. These warrants are exercisable at $11.50 per share and, if exercised, could result in material dilution to public shareholders.
• Limited Timeframe for Business Combination [high — operational]: HCM IV Acquisition Corp. has a limited timeframe of 24 months from the offering's closing to complete a business combination. Failure to do so will result in liquidation, potentially leading to a loss of invested capital for public shareholders.
• Working Capital Loan Conversion Risk [medium — financial]: Up to $1,500,000 in working capital loans from the sponsor may convert into 1,000,000 private placement warrants at $1.50 each. This conversion further increases the potential dilution for public shareholders.
• Potential Excise Tax on Redemptions [low — regulatory]: The company notes that proceeds in the trust account will not be used to pay for any potential excise tax under the Inflation Reduction Act of 2022 on redemptions or share repurchases. This could impact the net proceeds available to shareholders upon redemption or liquidation.
• Sponsor-Affiliated Administrative Fees [low — operational]: The company will pay an affiliate of the sponsor $35,000 monthly for administrative services. This ongoing expense, while standard for SPACs, highlights potential conflicts of interest and impacts the capital available for business combination efforts.
• Redemption Restrictions for Large Holders [medium — financial]: Shareholders holding 15% or more of the shares sold in the offering may be restricted from redeeming their shares without prior consent if a shareholder vote is held for the business combination. This could limit liquidity for significant investors.

Industry Context

The Special Purpose Acquisition Company (SPAC) market has seen significant activity, offering a faster route to public markets for target companies compared to traditional IPOs. However, the landscape is competitive, with numerous SPACs vying for attractive targets within a limited timeframe. Regulatory scrutiny and investor sentiment can significantly impact the success and valuation of SPACs and their subsequent business combinations.

Regulatory Implications

As a Cayman Islands exempted company, HCM IV Acquisition Corp. is subject to SEC regulations for its U.S. listing. The filing of Form S-1/A indicates ongoing compliance efforts. Potential excise taxes under the Inflation Reduction Act of 2022 on redemptions or share repurchases are a noted regulatory consideration.

What Investors Should Do

1. Carefully review the dilution impact of sponsor shares and private placement warrants.
2. Assess the sponsor's ability to identify and complete a suitable business combination within the 24-month timeframe.
3. Understand the terms and potential impact of working capital loan conversions.
4. Evaluate the potential conflicts of interest arising from sponsor-related fees and loans.

Key Dates

• 2025-11-24: Filing of S-1/A Amendment No. 1 — Provides updated details for the initial public offering, including structure, terms, and risks.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that is formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (HCM IV Acquisition Corp. is a SPAC seeking a business combination.)

Units

A combination of securities sold together in an offering, typically consisting of one share of common stock and a fraction of a warrant. (The offering consists of 25,000,000 units, each with one Class A ordinary share and one-fourth of a warrant.)

Redeemable Warrants

A type of option that gives the holder the right, but not the obligation, to purchase a security (usually stock) at a specified price within a certain timeframe. (Each unit includes a warrant exercisable at $11.50 per share.)

Class B ordinary shares

Shares typically held by the sponsor of a SPAC, often carrying different voting rights or conversion terms compared to Class A shares. (The sponsor holds 8,625,000 Class B ordinary shares, which are subject to dilution and conversion terms.)

Trust Account

An account established by a SPAC to hold the proceeds from the IPO until a business combination is completed or the SPAC liquidates. (The IPO proceeds of $250,000,000 will be placed in a trust account.)

Business Combination

The merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar transaction that a SPAC undertakes to combine with an operating company. (HCM IV Acquisition Corp. is seeking to complete an initial business combination within 24 months.)

Private Placement Warrants

Warrants sold directly to private investors, often sponsors or institutional investors, typically at a lower price than public warrants. (The sponsor and Cantor Fitzgerald are purchasing 4,666,667 private placement warrants.)

Dilution

The reduction in the ownership percentage of a shareholder resulting from the issuance of new shares or the exercise of options or warrants. (Significant dilution risks are present for public shareholders due to sponsor shares and warrants.)

Year-Over-Year Comparison

This is an initial public offering filing (S-1/A Amendment No. 1), therefore, there is no prior year filing to compare against. Key metrics such as revenue, net income, and margins are not applicable at this pre-IPO stage. The focus is on the offering structure, capital raise, and associated risks, particularly concerning dilution from sponsor shares and warrants.

Key Financial Figures

• $250,000,000 — O COMPLETION, DATED NOVEMBER 24, 2025 $250,000,000 HCM IV Acquisition Corp. 25,000,000
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $1.50 — hare at $11.50 per share, at a price of $1.50 per warrant, or $7,000,000 in the aggre
• $7,000,000 — re, at a price of $1.50 per warrant, or $7,000,000 in the aggregate (whether or not the un
• $4,000,000 — rrants at a price of $1.50 per warrant ($4,000,000 in the aggregate) in a private placemen
• $300,000 — ring or thereafter, we will repay up to $300,000 in loans made to us by our sponsor to c
• $35,000 — egin paying an affiliate of our sponsor $35,000 per month for office space and administ
• $1,500,000 — our initial business combination, up to $1,500,000 of such loans may be convertible into w
• $100,000 — xcise taxes), if any, payable and up to $100,000 of interest income to pay dissolution e
• $0.20 — 233,750,000 ____________ (1) Includes $0.20 per unit (including any units sold purs
• $5,000,000 — ption to purchase additional units), or $5,000,000 in the aggregate (whether or not the un
• $0.45 — closing of this offering. Also includes $0.45 per unit on units other than those sold
• $0.65 — option to purchase additional units and $0.65 per unit on units sold pursuant to the
• $11,250,000 — option to purchase additional units, or $11,250,000 in the aggregate or up to $13,687,500 i

Filing Documents

• ea0263512-02.htm (S-1/A) — 4026KB
• ea026351202ex23-1_hcm4.htm (EX-23.1) — 2KB
• 0001213900-25-114271.txt ( ) — 6842KB
• ck0002089982-20251124.xsd (EX-101.SCH) — 8KB
• ck0002089982-20251124_def.xml (EX-101.DEF) — 12KB
• ck0002089982-20251124_lab.xml (EX-101.LAB) — 116KB
• ck0002089982-20251124_pre.xml (EX-101.PRE) — 67KB
• ea0263512-02_htm.xml (XML) — 926KB

From the Filing

As filed with the Securities and Exchange Commission on November 24, 2025 Registration No. 333-291343 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _________________________ HCM IV Acquisition Corp. (Exact name of registrant as specified in its charter) _________________________ Cayman Islands 6770 98-1883478 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Shawn Matthews Chairman and Chief Executive Officer 100 First Stamford Place, Suite 330 Stamford, CT 06902 (203) 930-2200 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) _________________________ Shawn Matthews Chairman and Chief Executive Officer 100 First Stamford Place, Suite 330 Stamford, CT 06902 (203) 930-2200 (Name, address, including zip code, and telephone number, including area code, of agent for service) _________________________ Copies to: Kevin E. Manz King & Spalding LLP 1185 Avenue of the Americas, 34 th Floor New York, New York 10036 (212) 556-2100 Douglas S. Ellenoff Stuart Neuhauser Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas, 11 th Floor New York, New York 10105 (212) 370 -1300 _________________________ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine . Table of Contents The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. PRELIMINARY PROSPECTUS $250,000,000 HCM IV Acquisition Corp. 25,000,000 Units HCM IV Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry. This is an initia

View Full Filing

View this S-1/A filing on SEC EDGAR